DRKS00010926已完成不适用
EMIT-AF/VTE: Edoxaban management in diagnostic and therapeutic procedures - EMIT-AF/VTE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,464
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Patients taking edoxaban for a therapeutic indication according to the SmPC (NVAF, VTE including DVT and PE)
- •Paients with a planned or unplanned diagnostic or interventional procedure
- •Age = 18 years
- •Written informed consent
- •Availability of patients for follow-up by telephone
- •No concurrent participation in an interventional study
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Edoxaban Management in Diagnostic and Therapeutic ProceduresAtrial FibrillationVenous ThromboembolismNCT02950168Daiichi Sankyo1,197
已完成
不适用
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)Atrial FibrillationNCT03247582Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo Company234
已完成
不适用
Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF)Atrial FibrillationNCT03247569Daiichi Sankyo (Thailand) Ltd., a Daiichi Sankyo Company300
已完成
不适用
Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial FibrillationAtrial FibrillationNCT02944019Daiichi Sankyo13,980
已完成
不适用
Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN)Atrial FibrillationNCT02951039Daiichi Sankyo3,008